U.S. Army Medical Research and Development Command
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, U.S. Army Medical Research and Development Command sits in the top decile of US sponsors by registered trial count (#284 of 15,742 sponsors by registered trial count).
U.S. Army Medical Research and Development Command: 77 sponsored US clinical trials, 3 recruiting.
U.S. Army Medical Research and Development Command sponsors 77 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 71 completed. 0 of these trials are in Phase 3-4 (later-stage) and 70 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Malaria, with 6 trials.
Top-decile sponsor footprint
U.S. Army Medical Research and Development Command ranks in the top decile of sponsors by registered trial count (#284 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
71 of 73 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
77 total, page 2 of 2
A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya
NCT00666380
Phase 1 Safety and Immunogenicity of Meningococcal Vaccine
NCT00678652
Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection
NCT00485134
Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396
NCT00657917
NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1
NCT00392015
A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults
NCT00385047
Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine
NCT00415051
Study of the Safety of Intravenous Artesunate
NCT00292942
Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults
NCT00350337
Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America
NCT00312663
Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America
NCT00312702
Safety Evaluation of a Q-fever Vaccine, NDBR 105
NCT00584454
Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine
NCT00290147
Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.
NCT00248833
Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults
NCT00376090
Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine
NCT00283283
Use of Sodium Stibogluconate as a Treatment for Leishmaniasis
NCT00657618
Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine
NCT00584844
A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine
NCT00412477
Safety and Immunogenicity Study of Rift Valley Fever Vaccine
NCT00584194
Invaplex 50 Vaccine Dose-Ranging
NCT00082069
Vietnam Head Injury Study - Phase III
NCT00132249
Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis
NCT00884377
Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria
NCT00075049
Sodium Stibogluconate Treatment of Leishmaniasis
NCT00662012
Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S
NCT01556945
Study of the Safety of Intravenous Artesunate
NCT00292929
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 22 |
What is open in the U.S. Army Medical Research and Development Command pipeline
3 recruiting of 77 indexed (4% open); 71 completed (92%).
Phase mix: 0 late (III/IV) vs 70 early (I/II) (early-phase heavy).
Top condition: Malaria (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
U.S. Army Medical Research and Development Command: open-pipeline peers nationwide
Peers matched on 77 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
U.S. Army Medical Research and Development Command sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 77 trials (± recruiting share)
- University of Hawaii · 77 trials · 17% recruiting
- RAND · 78 trials · 8% recruiting
- Ionis Pharmaceuticals · 76 trials · 12% recruiting
- MetroHealth Medical Center · 76 trials · 13% recruiting
Sponsors near 4% open enrollment (± trial volume)
- Celgene · 4% recruiting · 308 trials
- MedtronicNeuro · 4% recruiting · 51 trials
- Aldeyra Therapeutics · 4% recruiting · 26 trials
- DexCom · 4% recruiting · 26 trials
Related
What to do with this U.S. Army Medical Research and Development Command page
77 registered trials is a research-attention snapshot, not an endorsement of U.S. Army Medical Research and Development Command or any single study.
- 3 of U.S. Army Medical Research and Development Command's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Malaria is the condition U.S. Army Medical Research and Development Command studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Malaria trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
U.S. Army Medical Research and Development Command pipeline card: 77 registered trials from official public datasets.Report a data error.